The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Substance P Activation of Rheumatoid Synoviocytes: Neural Pathway in Pathogenesis of Arthritis
Abstract
Several clinical features are consistent with nervous system involvement in the pathogenesis of rheumatoid arthritis. The neuropeptide substance P is one possible mediator of this interaction, since it can be released into joint tissues from primary sensory nerve fibers. The potential effects of the peptide on rheumatoid synoviocytes were examined. The results show that substance P stimulates prostaglandin E 2 and collagenase release from synoviocytes. Furthermore, synoviocyte proliferation was increased in the presence of the neuropeptide. Similar effects were observed with a truncated form of substance P. Synoviocytes were sensitive to very small doses of the neuropeptide (10 -9 M ), and its effects were inhibited by a specific antagonist. Thus, the specific stimulation of synoviocytes by the neuropeptide substance P represents a pathway by which the nervous system might be directly involved in the pathogenesis of rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation
Lembeck, F., & Holzer, P. (1979) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00500282 · Cited by 1,198
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Stimulation of connective tissue cell growth by substance P and substance K
Nilsson, J., von Euler, A. M., & Dalsgaard, C.-J. (1985) · Nature · doi:10.1038/315061a0 · Cited by 679
Mizel, S. B., Dayer, J. M., Krane, S. M., & Mergenhagen, S. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2474 · Cited by 612
Intraneuronal Substance P Contributes to the Severity of Experimental Arthritis
Levine, J. D., Clark, R., Devor, M., Helms, C., Moskowitz, M. A., & Basbaum, A. I. (1984) · Science · doi:10.1126/science.6208609 · Cited by 524
Brain-Derived Acidic Fibroblast Growth Factor: Complete Amino Acid Sequence and Homologies
Gimenez-Gallego, G., Rodkey, J., Bennett, C., Rios-Candelore, M., DiSalvo, J., & Thomas, K. (1985) · Science · doi:10.1126/science.4071057 · Cited by 329
Bar-Shavit, Z., Goldman, R., Stabinsky, Y., Gottlieb, P., Fridkin, M., Teichberg, V. I., & Blumberg, S. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)90581-1 · Cited by 310
Dayer, J. M., Bréard, J., Chess, L., & Krane, S. M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109596 · Cited by 281
Substance P: binding properties and studies on cellular responses in guinea pig macrophages.
Hartung, H. P., Wolters, K., & Toyka, K. V. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3856 · Cited by 256
Cited by
Rheumatoid Arthritis: Pathophysiology and Implications for Therapy
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,551
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
Sellam, J., & Berenbaum, F. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.159 · Cited by 1,500
Effect of Neuropeptides on Production of Inflammatory Cytokines by Human Monocytes
Lotz, M., Vaughan, J. H., & Carson, D. A. (1988) · Science · doi:10.1126/science.2457950 · Cited by 915
Self-citationA Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor
Snider, R. M., Constantine, J. W., Lowe, J. A., Longo, K. P., Lebel, W. S., Woody, H. A., Drozda, S. E., Desai, M. C., Vinick, F. J., Spencer, R. W., et al. (1991) · Science · doi:10.1126/science.1703323 · Cited by 859
Nociception from skeletal muscle in relation to clinical muscle pain
Mense, S. (1993) · Pain · doi:10.1016/0304-3959(93)90027-m · Cited by 842
The role of substance P in inflammatory disease
O'Connor, T. M., O'Connell, J., O'Brien, D. I., Goode, T., Bredin, C. P., & Shanahan, F. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20061 · Cited by 789
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
Tachykinin receptors and tachykinin receptor antagonists
Maggi, C. A., Patacchini, R., Rovero, P., & Giachetti, A. (1993) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1993.tb00396.x · Cited by 636
Afferent and spinal mechanisms of joint pain
Schaible, H.-G., & Grubb, B. D. (1993) · Pain · doi:10.1016/0304-3959(93)90183-p · Cited by 625
Neuropeptide substance P and the immune response
Mashaghi, A., Marmalidou, A., Tehrani, M., Grace, P. M., Pothoulakis, C., & Dana, R. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2293-z · Cited by 493
Peptides and the primary afferent nociceptor
Levine, J., Fields, H., & Basbaum, A. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02273.1993 · Cited by 485
Maggi, C. A. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(94)e0017-b · Cited by 470
Nagase, H., Enghild, J. J., Suzuki, K., & Salvesen, G. (1990) · Biochemistry · doi:10.1021/bi00476a020 · Cited by 389
Hong, H. S., Lee, J., Lee, E., Kwon, Y. S., Lee, E., Ahn, W., Jiang, M. H., Kim, J. C., & Son, Y. (2009) · Nature Medicine · doi:10.1038/nm.1909 · Cited by 349
Neurotransmitters, Cytokines, and the Control of Alveolar Bone Remodeling in Orthodontics
Davidovitch, Z., Nicolay, O. F., Ngan, P. W., & Shanfeld, J. L. (1988) · Dental Clinics of North America · doi:10.1016/s0011-8532(22)00320-2 · Cited by 320
Miller, L. E., Jüsten, H., Schcölmerich, J., & Straub, R. H. (2000) · The FASEB Journal · doi:10.1096/fj.99-1082com · Cited by 294
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
Quartara, L., & Maggi, C. A. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90015-4 · Cited by 292
Bhatia, M., Saluja, A. K., Hofbauer, B., Frossard, J.-L., Lee, H. S., Castagliuolo, I., Wang, C.-C., Gerard, N., Pothoulakis, C., & Steer, M. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4760 · Cited by 292
Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells
Ziche, M., Morbidelli, L., Pacini, M., Geppetti, P., Alessandri, G., & Maggi, C. A. (1990) · Microvascular Research · doi:10.1016/0026-2862(90)90024-l · Cited by 288
Neuropeptides and Inflammation: The Role of Substance P
Payan, D. G. (1989) · Annual Review of Medicine · doi:10.1146/annurev.me.40.020189.002013 · Cited by 281
The effectiveness of topically applied capsaicin: A meta-analysis
Zhang, W. Y., & Li Wan Po, A. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00196108 · Cited by 270
Hyperinnervation in Intestinal Deep Infiltrating Endometriosis
Wang, G., Tokushige, N., Russell, P., Dubinovsky, S., Markham, R., & Fraser, I. S. (2009) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.07.012 · Cited by 85
Jeng, A. Y., Fujimoto, R. A., Chou, M., Tan, J., & Erion, M. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14666 · Cited by 16
Metadata
- Authors
- Lotz, M., Carson, D. A., & Vaughan, J. H.
- Venue
- Science
- Published
- 1987-02-20
- Volume
- 235
- Issue
- 4791
- Pages
- 893-895
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035808396
- Cited by
- 444
- References
- 15
- FWCI
- 21.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.